Sight Sciences, Inc.
SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology forā¦ read more
Healthcare
Medical Devices
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$8.45
Price+2.30%
$0.19
1Y
Price
Market Cap
$446.766m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-34.3%
EBITDA Margin-41.0%
Net Profit Margin-44.6%
Free Cash Flow MarginRevenue
$76.052m
-4.8%
1y CAGR+2.5%
3y CAGR+13.3%
5y CAGREarnings
-$46.110m
+10.5%
1y CAGR+17.8%
3y CAGR+4.1%
5y CAGREPS
-$0.90
+12.6%
1y CAGR+19.7%
3y CAGR+5.9%
5y CAGRBook Value
$64.290m
$116.256m
Assets$51.966m
Liabilities$40.685m
DebtDebt to Assets
35.0%
-1x
Debt to EBITDAFree Cash Flow
-$31.843m
-40.1%
1y CAGR+16.7%
3y CAGR+1.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company